Aurobindo Pharma surges on receiving USFDA approval for Esomeprazole Magnesium Delayed-release Capsules

22 Apr 2016 Evaluate

Aurobindo Pharma is currently trading at Rs. 783.05, up by 15.40 points or 2.01% from its previous closing of Rs. 767.65 on the BSE.

The scrip opened at Rs. 767.00 and has touched a high and low of Rs. 786.10 and Rs. 759.00 respectively. So far 103515 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 891.50 on 30-Dec-2015 and a 52 week low of Rs. 582.00 on 25-Feb-2016.

Last one week high and low of the scrip stood at Rs. 794.40 and Rs. 760.80 respectively. The current market cap of the company is Rs. 45716.37 crore.

The promoters holding in the company stood at 53.79% while Institutions and Non-Institutions held 34.67% and 11.54% respectively.

Aurobindo Pharma has received final approval from US Food and Drugs Administration (USFDA) to manufacture and market Esomeprazole Magnesium Delayed-release Capsules USP, 20mg and 40mg. The launch of this product is based on the settlement terms/litigation outcome with AstraZeneca. The approved ANDA is bioequivalent to the reference listed drug product Nexium Delayed-release Capsules, 20mg and 40mg, of AstraZeneca Pharmaceuticals.

Esomeprazole Magnesium Delayed-release Capsules is used in the treatment of gastroesophageal reflex disease. The approved product has an estimated market size of $ 4.2 billion for 12 months ending February 2016 according to IMS.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments. The firm provides semi-synthetic penicillins that have a presence in therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.

Aurobindo Pharma Share Price

1167.20 -5.10 (-0.44%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×